Pentwater Capital Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-630,000
Closed -$542K 78
2024
Q1
$542K Sell
630,000
-70,000
-10% -$60.2K 0.01% 53
2023
Q4
$273K Buy
700,000
+101,560
+17% +$39.6K ﹤0.01% 66
2023
Q3
$958K Buy
598,440
+33,440
+6% +$53.5K 0.01% 56
2023
Q2
$1.65M Buy
565,000
+65,000
+13% +$190K 0.01% 62
2023
Q1
$1.21M Sell
500,000
-100,000
-17% -$242K 0.01% 69
2022
Q4
$1.12M Sell
600,000
-116,824
-16% -$218K 0.02% 61
2022
Q3
$918K Buy
716,824
+466,824
+187% +$598K 0.01% 87
2022
Q2
$613K Buy
250,000
+25,000
+11% +$61.3K 0.01% 102
2022
Q1
$1.56M Buy
225,000
+61,800
+38% +$428K 0.02% 92
2021
Q4
$2.6M Buy
163,200
+11,938
+8% +$190K 0.03% 82
2021
Q3
$3.03M Buy
151,262
+51,262
+51% +$1.03M 0.03% 91
2021
Q2
$3.09M Sell
100,000
-17,500
-15% -$540K 0.03% 100
2021
Q1
$3.02M Sell
117,500
-36,000
-23% -$924K 0.03% 103
2020
Q4
$2.46M Sell
153,500
-26,000
-14% -$416K 0.03% 82
2020
Q3
$2.19M Buy
+179,500
New +$2.19M 0.03% 85